The global extracorporeal membrane oxygenation (ECMO) machine market was valued at USD 202.1 million in 2020 and is expected to grow at a CAGR of 5.3% during the forecast period. Key drivers responsible for the market growth include rising cases of cardio-pulmonary disorders and respiratory problems across the globe.
Know more about this report: request for sample pages
According to the market statistics published by the Centers for Disease Control and Prevention (CDC), in the U.S. alone an individual dies every 37 seconds from such cardio-vascular disorders. In 2018, COPD is one of the leading causes of death in the country. Moreover, there is an increasing trend of adopting extracorporeal membrane oxygenation machine services by the hospitals, coupled with the awareness programs also influencing its growth.
As per the Federal Agency of Health Research and Quality, till 2018, around 6890 extracorporeal membrane oxygenation machine procedures were performed in the U.S. Thus, owing to such factors the adoption of extracorporeal membrane oxygenation machines in healthcare facilities has increased significantly.
The recent spike in COVID-19 patients has boosted the adoption of extracorporeal membrane oxygenation machines. As per the statistics published by the Extracorporeal Life Support Organization (ELSO), in 2019, the number of hospitals offering extracorporeal membrane oxygenation services has risen to 264 and is currently used for the treatment of COVID-19 patients.
Moreover, increasing awareness about extracorporeal membrane oxygenation services, coupled with technological advancements is further projected to propel the market growth. Several individual governments are pledged to spread awareness about the benefits of extracorporeal membrane oxygenation services in the market.
For instance, an initiative such as Global Initiative for Chronic Obstructive Lung Disease (GOLD) is a dedicated organization engaged in creating positive awareness among COPD patients to use extracorporeal membrane oxygenation machines in the market.
The market is primarily segmented on the basis of component, modality, patient type, application and geographic region.
By Patient Type
Know more about this report: request for sample pages
The oxygenator market segment accounted for the largest revenue share of more than 34%, in 2020. Such high share is attributed to its high preference over other systems. Its high efficiency is due to acute exchange rate, primarily due to pump head thrombosis, mechanical failure, and acute oxygenator thrombosis.
The pumps extracorporeal membrane oxygenation machine market segment is projected to register a lucrative growth rate over the assessment period. Market growth in the segment is due to the high adoption of pumps in extracorporeal membrane oxygenation machine procedures, and the availability of several types of pumps, such as impeller, and rollers. These pumps are used in several applications and could be customized according to the client’s requirements.
Based upon modality, the global extracorporeal membrane oxygenation machine market is categorized into veno-arterial, veno-venous, and arterio-venous. In 2020, the veno-arterial market segment accounted for the majority of the share during the assessment period. Such a high share is attributed to its high use in treating patients suffering from cardiac ailments.
Veno-venous market segment is projected to witness a lucrative growth rate over the assessment period. The adoption of extracorporeal membrane oxygenation services in the market segment is due to the rising incidence of COPD, across the globe. As per estimates of the WHO, in 2016, there were around 251 million cases of COPD and it is expected that number is expected to rise significantly in the coming years. Thus, the segment will exhibit a positive growth trajectory.
Based upon application, the global extracorporeal membrane oxygenation machine market is categorized into respiratory, cardiac, and ECPR. In 2020, the respiratory market segment accounted for the majority of the share during the assessment period. Key drivers influencing the market segment’s growth include the rising prevalence of respiratory diseases and associated ill effects. As per the statistics published by the ELSO, more than 2,600 people in the U.S. alone, suffer from respiratory problems.
The cardiac surgery extracorporeal membrane oxygenation machine market segment is expected to register a lucrative growth rate over the study period. Rising cardiac surgeries and the use of extracorporeal membrane oxygenation machines in such surgeries likely to shape the segment’s future.
According to estimates of the American Heart Association, in 2016, around 1 in every 3 people in the U.S. die with cardiovascular disorder and it is expected that the direct medical cost of such heart-related ailments is projected to reach more than USD 749 million, by 2035.
North America extracorporeal membrane oxygenation machine industry accounted for the majority of the share. Region’s market growth is attributed to the rising prevalence of target diseases such as COPD in both U.S. and Canada, the government’s commitment towards quality healthcare, the presence of key players with innovative solutions, and the high purchasing power capacity of hospitals.
Moreover, the presence of sophisticated healthcare infrastructure, with high disposable income of patients led to an increase in the hospital admission rates, which, in turn, also favored the region’s growth prospects.
The prominent players operating in the extracorporeal membrane oxygenation machine industry are MAQUET Holding B.V., Medtronic plc, Nipro Medical Corporation, Sorin Group, Terumo Cardiovascular Systems, Medos Medizintechnik AG, and Microport Scientific.